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Introduction
Before 1985, when anti-HIV screening of blood dona-
tions was introduced [1], in Germany several hundred peo-
ple (not counting haemophiliacs) had been infected by
blood products that had not been tested [2]. In 1994, guide-
lines were issued for the ‘look-back’ of transfusion-associ-
ated HIV, HBV, and HCV infections [3]. The aim was (1) to
find all recipients of potentially infected blood donated by a
person found to have seroconverted at a subsequent blood
donation, and (2) to find the donor, who has infected some-
one by blood transfusion, in order to prevent further infec-
tions caused by blood donations of this donor and to find all
other recipients of blood from this donor, who might also
have been infected.
We present here the case of a patient whose blood trans-
fusion was the only apparent risk for HIV infection. We al-
so report our method of identifying the route of infection 12
years earlier.
Case Report
In 1996, a 59-year-old woman became ill with pneumonia for the
third time in several months. A screening test for anti-HIV-1/2 was
positive. In the HIV-1 immunoblot, antibodies against the following
antigens were detected: p24 (weak), p32 (weak), gp41, p51, p55, p66,
and gp120. The HIV-2 immunoblot showed weak reactions with the
antigens p25 and p55. These were interpreted as cross-reactions by
the HIV-1 antibodies.
After recovery from respiratory infection, the patient was trans-
ferred to our department for further treatment. On admission, she had
2,700 leucocytes/íl with 38% lymphocytes. The absolute count of
CD4+ lymphocytes was low (31/íl). No other opportunistic infec-
tions were observed.
The only risk factor for HIV infection was transfusion of three
units of blood during a surgical intervention in 1984, when anti-HIV
tests for donor screening were not yet available. Two of the donors in-
volved were tested for HIV antibodies several years later at the time
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Abstract
Background and Objectives: We tested dried blood from an ABO bedside test
card which had been stored at room temperature for 12 years, to prove that a pa-
tient with HIV-1 infection had been infected by blood transfusion. Materials
and Methods: Immunoblots for HIV-1 antibodies and threefold PCRs with half-
nested primers for the HIV-1 integrase gene were done with eluates from the
dried blood spots. Results: HIV-1 antibodies and HIV-1 DNA could be detected
in the sample from one unit of blood, but not from the two other units or from the
recipient before transfusion. Conclusion: Further studies should be done on the
validity of stored dried blood as an alternative to the storage of frozen donor
serum for several years for ‘look-back’ studies.
This paper was presented as a poster at the Joint Congress of the Interna-
tional Society of Blood Transfusion (ISBT, European Section) and the
Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie
(DGTI) in Frankfurt, Germany (October 1–4, 1997).
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of further blood donations and were found to be anti-HIV-negative
(donor 1 in 1987, donor 3 in 1988). Donor 2 was tested 1 year later
(1985) and found to be anti-HIV-positive. In 1985, look-backs for
recipients of such a donor’s blood were unusual.
Materials and Methods
Blood spots from the recipient and the 3 donors had been pre-
served on a bedside test card with anti-A, anti-B and anti-D reagents
in 1984. These were examined. The spots of dried blood on this card
had been covered by an adhesive film and the card had been stored to-
gether with the patient’s records at room temperature for 12 years.
The adhesive film was removed and the dried blood (2 of the 3
spots from each blood sample with a diameter of about 1.5 cm each)
was scraped off and transferred together with a small part of the paper
into a polypropylene tube.
To extract antibodies and remove haemoglobin, each dried blood
sample was incubated with 1 ml lysis buffer (0.16 M NH4Cl; 0.17 M
Tris; pH 7.2) overnight at room temperature and for 2 h at 45°C. The
supernatant was used for detection of HIV antibodies. A second elu-
tion procedure was done to remove most of the remaining haemo-
globin.
Lysis buffer was removed by centrifugation and aspiration, subse-
quently 200 íl buffer A (100 mM KCl; 10 mM Tris; 2.5 mM MgCl2;
pH 8.3) and 100 íg proteinase K in 200 íg buffer B (10 mM Tris; 2.5
mM MgCl2; 1% Tween-20; 1% NP-40) were added to each sample to
liberate human and proviral DNA. After incubation at 65°C for 4 h
(with continous shaking) and at 95°C for 5 min, the tubes were cen-
trifuged for 7 min at 5,000 g. Each supernatant was diluted with dis-
tilled water to 1 ml and DNA was purified by QIAamp™ columns 
(QIAamp™ Kit, Diagen GmbH, Hilden, Germany) resulting in 50 íl
DNA solution, from which 7 íl were used for each PCR test. HIV-1
antibodies were detected by an immunoblot technique using antigens
from the HIV-1 isolate MVP-899 [4].
To demonstrate successful extraction of human DNA from the
dried blood spots, a fragment of the chemokine receptor-5 (CKR-5)
gene was amplified by PCR, as described by Liu et al. [5].
Several double PCRs with nested primers were used to detect
proviral DNA for HIV-1 as described previously (table 1) [6]. As no
amplification product was obtained, three half-nested PCRs were per-
formed using primers of the HIV-1 integrase gene (table 1). For nu-
cleic acid amplification by PCR, we chose the following conditions:
30 cycles for each round of replication, denaturation 30 s at 92°C, an-
nealing 1 min at 55°C, and extension 1 min at 72°C. For the combi-
nation of 3 half-nested PCRs, an annealing temperature of 50°C was
selected to obtain maximal sensitivity. In all PCR procedures, DNA
extracted from cells infected with the HIV-1 isolate MVP-899 served
as control.
Amplification products were subjected to electrophoresis in
agarose gel (2.5%) and identified by ethidium bromide staining of
DNA. Specificity was confirmed by agreement with the calculated
molecular weight of the amplification product and by comparison
with the amplification product of the control DNA.
Results
Antibodies to HIV-1 were found only in the lysis buffer
extract of the dried blood spots of donor 2, not of the recip-
ient or donors 1 and 3. The antibodies of donor 2 were
directed against the following HIV-1 antigens: p32, gp41,
p51, p55, p66 and gp120.
Succesful extraction of human DNA from all four dried
blood samples was demonstrated by PCR amplification of 
a fragment of the CKR-5 gene with a molecular weight of
1,060 bp.
Double PCRs with nested primers for the HIV-1 proviral
gag, env, pol-reverse transcriptase and integrase gene did
not reveal any amplification product from the dried blood
samples of the recipient and the three donors. Threefold
PCRs with half-nested primers for the proviral integrase
gene showed no specific amplification products from the
HIV gene 1st-round primers 2nd-round primers 3rd-round primers
Double PCRs
gag gaga:gagb sk38:sk39
pol-RT pol3:pol4 pol3n:pol4n
env enva:envb sk68:sk69
pol-integrase 5pol201:3pol301 5pol211:3pol291
Threefold PCR
pol-integrase 5pol201:3pol301 5pol211:3pol301 5pol211:3pol291
Sequences of the primers (5*d3*) for the HIV-1 integrase gene:
5pol201: GTGAA TCAGA AATAG TCAGT C,
3pol301: ATCAT CACCT GCCAT CTG,
5pol211: CATGG GTACC AGCAC CACAA AG,
3pol291: AGTGG ATCTC TGCTG TCCCT G.
Table 1. Primers used for PCR to detect
HIV-1 proviral DNA in eluates from dried
blood spots from a 12-year-old ABO bedside
test card
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dried blood samples of the recipient and of blood donors 1
and 3. Only in the dried blood spot of donor 2 was the spe-
cific amplification product with the predicted molecular
weight of 650 bp found. The detection of proviral HIV-1
DNA only in the blood sample of donor 2, not in those of the
recipient (taken immediately before blood transfusion) and
of the two other blood donors, confirms that blood from
donor 2 was the source of the HIV-1 infection of our patient
in 1984.
Discussion
Several studies have been reported on the use of spots of
dried blood on filter paper for HIV testing (for example, of
newborns or persons living in remote areas) by means of
PCR [7–10]. Other reports describe the successful use of such
blood spots in newborns for the detection of maternal HIV
[11, 12] or HTLV-I [13] antibodies for epidemiological pur-
poses. Also HBs antigen and other markers of HBV infection
have already been detected in dried blood spots [14, 15].
Furthermore, dried sera on blotting paper have been
transported over long distances for testing anti-HIV, anti-
HTLV-I and anti-HCV [16, 17]. If experiments with more
samples prove the validity of their results, Das et al. [17]
propose to send dried sera of blood donors with positive re-
sults in screening tests from developing countries to refer-
ence laboratories in industrialized countries to perform con-
firmation tests.
As our study demonstrates, the examination of dried
blood can also help to overcome lapses of time, since we
identified the route of infection of a patient by means of
HIV testing of spots of dried blood on a 12-year-old ABO
bedside test card. This is not only of forensic interest, but
may also have practical importance for blood donation ser-
vices as Germany has regulations requiring storage of
serum or plasma samples for at least 1 year after the expira-
tion date of blood products [18].
For these reasons, we propose to carry out further studies
on the validity of storing dried whole blood and dried serum
or plasma for several years after blood donation as an alter-
native to the more expensive storage of frozen donor serum.
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